Cathie Wood’s ARK Invest Adjusts Portfolio with Focus on Electric Aviation and Biotech

Cathie Wood's ARK ETFs made significant moves on January 29, 2026, capitalizing on market volatility to reinforce positions in disruptive technologies. The firm acquired 781,519 shares of Joby Aviation worth $10.4 million after the stock plunged 16.7% on dilution concerns from a $1 billion capital raise. This purchase was executed through ARK's Autonomous Technology & Robotics ETF and Space Exploration & Innovation ETF.

ARK continued doubling down on biotech with a $6.8 million addition to its CRISPR Therapeutics position. Meanwhile, the investment firm demonstrated disciplined profit-taking by selling Teradyne shares NEAR all-time highs, netting $7.9 million as the semiconductor stock peaked following a joint venture announcement.

The trades reflect ARK's signature strategy of buying innovation-led companies during temporary setbacks while trimming winners at peak valuations. Joby Aviation's air taxi ambitions and CRISPR's gene-editing technology remain cornerstone convictions, despite near-term headwinds.